ARCHIVES

Conference Level For NCI Is 5.4% Over FY 1990

This article is from The Cancer Letter archive.

Vol. 16 No. 42 | November 2, 1990

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

July 30, 2010

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

In Brief: Visco Elected Chairman of DOD Panel; Breast Cancer Stamp Raises $4.9 Million

February 19, 1999

It is The First FDA Withdrawl Of An Accelerated Approval

November 18, 2011

In Brief: House Bill Boosts NIH Funding By $1.2 Billion; ASCO Counted More Than 17,000 Registrants

June 26, 1998

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

May 4, 2007